
Dallas-based Lung Institute: Pioneers in regenerative medicine, offering innovative, minimally invasive stem cell therapies for debilitating lung disorders.
Founded in Dallas, the Lung Institute is a pioneering healthcare organization focused on regenerative medicine. Their core mission is to offer innovative, minimally invasive stem cell therapies to treat debilitating lung disorders such as chronic obstructive pulmonary disorder (COPD), pulmonary fibrosis, emphysema, and interstitial lung disease. The Lung Institute aims to improve patients' quality of life by providing more effective treatment options for these severe pulmonary conditions.
The Lung Institute has garnered global recognition through the expertise of its physicians and their dedicated practices. Notable achievements include advancements in stem cell therapy techniques that have significantly impacted patient outcomes. The organization has also attracted attention from leading investors in the healthcare sector, further solidifying its reputation as a leader in regenerative medicine. Through its innovative treatments, the Lung Institute has made a substantial impact on the lives of those suffering from chronic lung diseases.

Celltex Therapeutics
celltexbank.com

AlphaStem
alpha-stim.com

Pulmatrix
pulmatrix.com

U.S. Stem Cell
us-stemcell.com
Regen BioPharma

Personalized Stem Cells

Gallant

Pulmonx
pulmonx.com

Hepatx
hepatx.com
Lung Biotechnology
unither.com

Stemcyte
stemcyte.com

Regenerative Medical Solutions

Ossium Health
ossiumhealth.com

InGeneron
ingeneron.com

APstem Therapeutics
apstemtx.com

ImStem Biotechnology
imstem.com

Stem Cell Reserve

Alveolus Bio
alveolusbio.com

Antria
antria.org

Convalesce
convalesce.co
Lung Institute's most recent funding round was for $232k (USD) in March 2015.
As of Mar 31, 2015, Lung Institute has disclosed funding of $232k (USD).